{
"info": {
"nct_id": "NCT06135194",
"official_title": "Efficacy and Safety of T-Dxd in the Treatment of HER2-positive Breast Cancer With Brain Metastases After Prior Pyrotinib Treatment",
"inclusion_criteria": "(1) Women ≥18 years of age :(2) pathological diagnosis of HER2-positive breast cancer, defined as positive immunohistochemistry detection (+++) or FISH(Fluorescent In Situ Hybridization); (3) Imaging evidence of brain metastases; (4) Progression of brain metastases after prior treatment with pyrotinib, defined as progression of new or pre-existing brain metastases during treatment with pyrotinib; (5)ECOG score ≤3 points; (6) The efficacy of T-DXd should be evaluated at least once after treatment; (7) Bone marrow and organ functions are basically normal; (8) Complete medical records\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years\nMust have maximum age of 80 Years",
"exclusion_criteria": "* Has uncontrolled or significant cardiovascular disease\n* Has history of (noninfectious) interstitial lung disease (ILD)/pneumonitis that required steroids, has current ILD/pneumonitis, or suspected ILD/ pneumonitis that cannot be ruled out by imaging at screening\n* Has any medical history or condition that per protocol or in the opinion of the investigator is inappropriate for the study",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"identified_line": {
"line": "(1) Women ≥18 years of age :(2) pathological diagnosis of HER2-positive breast cancer, defined as positive immunohistochemistry detection (+++) or FISH(Fluorescent In Situ Hybridization); (3) Imaging evidence of brain metastases; (4) Progression of brain metastases after prior treatment with pyrotinib, defined as progression of new or pre-existing brain metastases during treatment with pyrotinib; (5)ECOG score ≤3 points; (6) The efficacy of T-DXd should be evaluated at least once after treatment; (7) Bone marrow and organ functions are basically normal; (8) Complete medical records",
"criterions": [
{
"exact_snippets": "Women ≥18 years of age",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
},
{
"exact_snippets": "pathological diagnosis of HER2-positive breast cancer",
"criterion": "HER2-positive breast cancer",
"requirement": {
"requirement_type": "diagnosis",
"expected_value": true
}
},
{
"exact_snippets": "positive immunohistochemistry detection (+++) or FISH(Fluorescent In Situ Hybridization)",
"criterion": "HER2-positive breast cancer",
"requirement": {
"requirement_type": "detection method",
"expected_value": [
"immunohistochemistry (+++)",
"FISH (Fluorescent In Situ Hybridization)"
]
}
},
{
"exact_snippets": "Imaging evidence of brain metastases",
"criterion": "brain metastases",
"requirement": {
"requirement_type": "imaging evidence",
"expected_value": true
}
},
{
"exact_snippets": "Progression of brain metastases after prior treatment with pyrotinib",
"criterion": "progression of brain metastases",
"requirement": {
"requirement_type": "after treatment with pyrotinib",
"expected_value": true
}
},
{
"exact_snippets": "ECOG score ≤3 points",
"criterion": "ECOG score",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 3,
"unit": "points"
}
}
},
{
"exact_snippets": "The efficacy of T-DXd should be evaluated at least once after treatment",
"criterion": "efficacy evaluation of T-DXd",
"requirement": {
"requirement_type": "evaluation frequency",
"expected_value": "at least once after treatment"
}
},
{
"exact_snippets": "Bone marrow and organ functions are basically normal",
"criterion": "bone marrow and organ functions",
"requirement": {
"requirement_type": "normality",
"expected_value": "basically normal"
}
},
{
"exact_snippets": "Complete medical records",
"criterion": "medical records",
"requirement": {
"requirement_type": "completeness",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Women ≥18 years of age",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
},
{
"exact_snippets": "pathological diagnosis of HER2-positive breast cancer",
"criterion": "HER2-positive breast cancer",
"requirement": {
"requirement_type": "diagnosis",
"expected_value": true
}
}
]
},
{
"exact_snippets": "positive immunohistochemistry detection (+++) or FISH(Fluorescent In Situ Hybridization)",
"criterion": "HER2-positive breast cancer",
"requirement": {
"requirement_type": "detection method",
"expected_value": [
"immunohistochemistry (+++)",
"FISH (Fluorescent In Situ Hybridization)"
]
}
}
]
},
{
"exact_snippets": "Imaging evidence of brain metastases",
"criterion": "brain metastases",
"requirement": {
"requirement_type": "imaging evidence",
"expected_value": true
}
}
]
},
{
"exact_snippets": "Progression of brain metastases after prior treatment with pyrotinib",
"criterion": "progression of brain metastases",
"requirement": {
"requirement_type": "after treatment with pyrotinib",
"expected_value": true
}
}
]
},
{
"exact_snippets": "ECOG score ≤3 points",
"criterion": "ECOG score",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 3,
"unit": "points"
}
}
}
]
},
{
"exact_snippets": "The efficacy of T-DXd should be evaluated at least once after treatment",
"criterion": "efficacy evaluation of T-DXd",
"requirement": {
"requirement_type": "evaluation frequency",
"expected_value": "at least once after treatment"
}
}
]
},
{
"exact_snippets": "Bone marrow and organ functions are basically normal",
"criterion": "bone marrow and organ functions",
"requirement": {
"requirement_type": "normality",
"expected_value": "basically normal"
}
}
]
},
{
"exact_snippets": "Complete medical records",
"criterion": "medical records",
"requirement": {
"requirement_type": "completeness",
"expected_value": true
}
}
]
},
{
"exact_snippets": "positive immunohistochemistry detection (+++) or FISH(Fluorescent In Situ Hybridization)",
"criterion": "HER2-positive breast cancer",
"requirement": {
"requirement_type": "detection method",
"expected_value": [
"immunohistochemistry (+++)",
"FISH (Fluorescent In Situ Hybridization)"
]
}
}
]
}
},
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
}
},
{
"identified_line": {
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirement": {
"requirement_type": "N/A",
"expected_value": "FEMALE"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirement": {
"requirement_type": "N/A",
"expected_value": "FEMALE"
}
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
}
},
{
"identified_line": {
"line": "Must have maximum age of 80 Years",
"criterions": [
{
"exact_snippets": "maximum age of 80 Years",
"criterion": "age",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 80,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "maximum age of 80 Years",
"criterion": "age",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 80,
"unit": "Years"
}
}
}
]
}
}
],
"exclusion_lines": [
{
"identified_line": {
"line": "* Has uncontrolled or significant cardiovascular disease",
"criterions": [
{
"exact_snippets": "uncontrolled or significant cardiovascular disease",
"criterion": "cardiovascular disease",
"requirement": {
"requirement_type": "control",
"expected_value": false
}
},
{
"exact_snippets": "uncontrolled or significant cardiovascular disease",
"criterion": "cardiovascular disease",
"requirement": {
"requirement_type": "severity",
"expected_value": "significant"
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "uncontrolled or significant cardiovascular disease",
"criterion": "cardiovascular disease",
"requirement": {
"requirement_type": "control",
"expected_value": false
}
},
{
"exact_snippets": "uncontrolled or significant cardiovascular disease",
"criterion": "cardiovascular disease",
"requirement": {
"requirement_type": "severity",
"expected_value": "significant"
}
}
]
}
},
{
"identified_line": {
"line": "* Has history of (noninfectious) interstitial lung disease (ILD)/pneumonitis that required steroids, has current ILD/pneumonitis, or suspected ILD/ pneumonitis that cannot be ruled out by imaging at screening",
"criterions": [
{
"exact_snippets": "Has history of (noninfectious) interstitial lung disease (ILD)/pneumonitis that required steroids",
"criterion": "history of interstitial lung disease (ILD)/pneumonitis",
"requirement": {
"requirement_type": "treatment",
"expected_value": "required steroids"
}
},
{
"exact_snippets": "has current ILD/pneumonitis",
"criterion": "current interstitial lung disease (ILD)/pneumonitis",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "suspected ILD/ pneumonitis that cannot be ruled out by imaging at screening",
"criterion": "suspected interstitial lung disease (ILD)/pneumonitis",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "cannot be ruled out by imaging at screening"
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Has history of (noninfectious) interstitial lung disease (ILD)/pneumonitis that required steroids",
"criterion": "history of interstitial lung disease (ILD)/pneumonitis",
"requirement": {
"requirement_type": "treatment",
"expected_value": "required steroids"
}
}
]
},
{
"exact_snippets": "has current ILD/pneumonitis",
"criterion": "current interstitial lung disease (ILD)/pneumonitis",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "suspected ILD/ pneumonitis that cannot be ruled out by imaging at screening",
"criterion": "suspected interstitial lung disease (ILD)/pneumonitis",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "cannot be ruled out by imaging at screening"
}
}
]
}
},
{
"identified_line": {
"line": "* Has any medical history or condition that per protocol or in the opinion of the investigator is inappropriate for the study",
"criterions": [
{
"exact_snippets": "any medical history or condition",
"criterion": "medical history or condition",
"requirement": {
"requirement_type": "appropriateness for the study",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "any medical history or condition",
"criterion": "medical history or condition",
"requirement": {
"requirement_type": "appropriateness for the study",
"expected_value": false
}
}
]
}
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}